No profile data available.
CMS (CHSYF) is a healthcare company in the multi-therapeutic drug manufacturing industry, based in North Point, Hong Kong, with about 6,415 full-time employees.
It reported revenue of 8.21 billion CNY for fiscal year 2025, up 9.9% from fiscal year 2024, and net income of 1.49 billion CNY. Its market capitalization was $3.82 billion as of October 8, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 8, 2026.
China Medical System Holdings Limited, an investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People's Republic of China.
CMS reported 8.21 billion CNY in revenue for fiscal year 2025, up 9.9% from 7.47 billion HKD in fiscal year 2024.
$3.82 billion as of October 8, 2026.
Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Grifols, S.a. (GRFS), Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. (GEDSF), Aspen Pharmacare Holdings Limited (APNHY), Organon & Co. (OGN).